Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005654 | nucleoplasm | 2 | 1 |
GO:0005737 | cytoplasm | 2 | 1 |
GO:0032838 | plasma membrane bounded cell projection cytoplasm | 4 | 1 |
GO:0097014 | ciliary plasm | 5 | 1 |
GO:0099568 | cytoplasmic region | 3 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A0A3Q8IB11
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_PCSK_KEX2_1 | 125 | 127 | PF00082 | 0.546 |
CLV_PCSK_KEX2_1 | 95 | 97 | PF00082 | 0.485 |
CLV_PCSK_PC1ET2_1 | 125 | 127 | PF00082 | 0.546 |
CLV_PCSK_PC1ET2_1 | 95 | 97 | PF00082 | 0.505 |
DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.530 |
DOC_USP7_MATH_1 | 106 | 110 | PF00917 | 0.535 |
LIG_deltaCOP1_diTrp_1 | 102 | 107 | PF00928 | 0.390 |
LIG_FHA_1 | 60 | 66 | PF00498 | 0.433 |
LIG_FHA_1 | 99 | 105 | PF00498 | 0.509 |
LIG_FHA_2 | 48 | 54 | PF00498 | 0.476 |
LIG_GBD_Chelix_1 | 25 | 33 | PF00786 | 0.386 |
LIG_LIR_Gen_1 | 102 | 113 | PF02991 | 0.382 |
LIG_LIR_Gen_1 | 114 | 119 | PF02991 | 0.333 |
LIG_LIR_Gen_1 | 19 | 29 | PF02991 | 0.367 |
LIG_LIR_Gen_1 | 39 | 48 | PF02991 | 0.347 |
LIG_LIR_Gen_1 | 59 | 68 | PF02991 | 0.377 |
LIG_LIR_Nem_3 | 102 | 108 | PF02991 | 0.372 |
LIG_LIR_Nem_3 | 114 | 118 | PF02991 | 0.323 |
LIG_LIR_Nem_3 | 19 | 25 | PF02991 | 0.393 |
LIG_LIR_Nem_3 | 39 | 45 | PF02991 | 0.467 |
LIG_LIR_Nem_3 | 59 | 64 | PF02991 | 0.426 |
LIG_LIR_Nem_3 | 82 | 86 | PF02991 | 0.454 |
LIG_Pex14_2 | 118 | 122 | PF04695 | 0.337 |
LIG_Pex14_2 | 32 | 36 | PF04695 | 0.345 |
LIG_SH2_STAP1 | 115 | 119 | PF00017 | 0.410 |
LIG_SH2_STAP1 | 61 | 65 | PF00017 | 0.376 |
LIG_SH2_STAT5 | 61 | 64 | PF00017 | 0.379 |
LIG_SUMO_SIM_anti_2 | 87 | 94 | PF11976 | 0.373 |
LIG_TRAF2_1 | 85 | 88 | PF00917 | 0.330 |
LIG_WRC_WIRS_1 | 33 | 38 | PF05994 | 0.441 |
LIG_WRC_WIRS_1 | 61 | 66 | PF05994 | 0.424 |
MOD_CK2_1 | 60 | 66 | PF00069 | 0.452 |
MOD_CK2_1 | 82 | 88 | PF00069 | 0.594 |
MOD_GSK3_1 | 56 | 63 | PF00069 | 0.517 |
MOD_Plk_2-3 | 82 | 88 | PF00069 | 0.367 |
MOD_Plk_2-3 | 98 | 104 | PF00069 | 0.461 |
MOD_Plk_4 | 56 | 62 | PF00069 | 0.446 |
MOD_Plk_4 | 88 | 94 | PF00069 | 0.489 |
TRG_DiLeu_BaEn_1 | 88 | 93 | PF01217 | 0.383 |
TRG_DiLeu_BaEn_2 | 3 | 9 | PF01217 | 0.545 |
TRG_DiLeu_BaEn_3 | 102 | 108 | PF01217 | 0.414 |
TRG_DiLeu_BaEn_3 | 4 | 10 | PF01217 | 0.641 |
TRG_ENDOCYTIC_2 | 115 | 118 | PF00928 | 0.392 |
TRG_ENDOCYTIC_2 | 61 | 64 | PF00928 | 0.423 |
TRG_ENDOCYTIC_2 | 83 | 86 | PF00928 | 0.522 |
TRG_ER_diLys_1 | 123 | 127 | PF00400 | 0.490 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I435 | Leptomonas seymouri | 67% | 100% |
A0A0S4JEB2 | Bodo saltans | 41% | 74% |
A0A1X0P6P8 | Trypanosomatidae | 45% | 88% |
A0A422NWK1 | Trypanosoma rangeli | 45% | 100% |
A4H9B7 | Leishmania braziliensis | 86% | 100% |
A4HXN8 | Leishmania infantum | 99% | 100% |
D0A014 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 46% | 100% |
E9ARE9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 95% | 100% |
Q4QE30 | Leishmania major | 94% | 100% |
V5D5T3 | Trypanosoma cruzi | 46% | 100% |